IN2014DN07797A - - Google Patents

Info

Publication number
IN2014DN07797A
IN2014DN07797A IN7797DEN2014A IN2014DN07797A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A IN 7797DEN2014 A IN7797DEN2014 A IN 7797DEN2014A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A
Authority
IN
India
Prior art keywords
disintegrating
components
tablet
wet granulation
component
Prior art date
Application number
Other languages
English (en)
Inventor
Takahiro Hiramura
Kiyoshi Ikura
Sae Ishikawa
Tomohito Okabayashi
Naohiro Hashikawa
Tetsuro Morita
Kimiko Ikeda
Haruka WAKAYAMA
Original Assignee
Daicel Corp
Nichirin Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49260166&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN07797(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daicel Corp, Nichirin Chemical Ind filed Critical Daicel Corp
Publication of IN2014DN07797A publication Critical patent/IN2014DN07797A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
IN7797DEN2014 2012-03-29 2013-03-27 IN2014DN07797A (enExample)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2012075832 2012-03-29
JP2012206896 2012-09-20
JP2012206895 2012-09-20
JP2012275942 2012-12-18
PCT/JP2013/059083 WO2013146917A1 (ja) 2012-03-29 2013-03-27 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
IN2014DN07797A true IN2014DN07797A (enExample) 2015-05-15

Family

ID=49260166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7797DEN2014 IN2014DN07797A (enExample) 2012-03-29 2013-03-27

Country Status (8)

Country Link
US (2) US20150174075A2 (enExample)
EP (1) EP2832350B1 (enExample)
JP (1) JP5996633B2 (enExample)
KR (1) KR101707938B1 (enExample)
CN (1) CN104080443B (enExample)
IN (1) IN2014DN07797A (enExample)
TW (1) TWI610691B (enExample)
WO (1) WO2013146917A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080443B (zh) 2012-03-29 2017-12-12 株式会社大赛璐 含酸式羧甲基纤维素的崩解性颗粒组合物的制法、及该组合物和含该组合物的口腔崩解片剂
CN104010663B (zh) 2012-09-20 2021-02-19 株式会社大赛璐 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂
US20160136097A1 (en) * 2013-07-06 2016-05-19 Daicel Corporation Ultrafast-disintegrating tablet and method for manufacturing same
JP6302921B2 (ja) * 2013-09-27 2018-03-28 株式会社ダイセル 崩壊性粒子組成物を含む口腔内崩壊錠剤
US9974738B2 (en) 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
JP2017036214A (ja) * 2013-12-10 2017-02-16 株式会社ダイセル 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤
JP6566934B2 (ja) * 2014-04-21 2019-08-28 株式会社ダイセル 微小繊維状セルロースを含む崩壊性粒子組成物
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
CA2968210A1 (en) 2014-11-24 2016-06-02 Daicel Corporation A disintegrative particulate composition comprising milled lactose or granulated lactose
WO2016098459A1 (ja) * 2014-12-17 2016-06-23 株式会社ダイセル 遅延崩壊性粒子組成物
JP6513702B2 (ja) * 2014-12-25 2019-05-15 株式会社ダイセル 超速崩壊錠剤及びその製造方法
JP5897196B1 (ja) * 2015-10-05 2016-03-30 大同化成工業株式会社 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法
TWI767923B (zh) 2016-07-27 2022-06-21 日商澤井製藥股份有限公司 口腔內崩解錠添加用組成物及其製造方法以及口腔內崩解錠
JP6651638B2 (ja) 2016-09-06 2020-02-19 沢井製薬株式会社 口腔内崩壊錠添加用組成物
JPWO2020022053A1 (ja) * 2018-07-25 2021-08-02 株式会社ダイセル 微小繊維状セルロースを含み、賦形剤は含まない崩壊性粒子組成物
WO2020246120A1 (ja) * 2019-06-07 2020-12-10 あゆみ製薬株式会社 口腔内崩壊錠及びその製造方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP2000273039A (ja) 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
US7510728B2 (en) * 2000-10-06 2009-03-31 Takeda Pharmaceutical Company Limited Solid preparations
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
KR20080083071A (ko) 2003-08-08 2008-09-12 아지노모토 가부시키가이샤 나테글리니드 함유 제제
US20080274178A1 (en) * 2005-08-10 2008-11-06 Shionogi & Co., Ltd. Orally Disintegrating Tablet
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
EP2394643B1 (en) * 2006-11-17 2015-09-02 Supernus Pharmaceuticals, Inc. Sustained-release formulations of topiramate
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
EP2164462B1 (de) 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US20110053942A1 (en) * 2008-02-13 2011-03-03 Dainippon Sumitomo Pharma Co., Ltd. Orally disintegrating tablets
KR101704156B1 (ko) * 2008-11-25 2017-02-07 미쓰비시 타나베 파마 코퍼레이션 구강 내 속붕괴성정을 제조하기 위한 혼합물
JP5674666B2 (ja) 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
CN102548542B (zh) 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
US9198861B2 (en) * 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US20110150989A1 (en) * 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP5630902B2 (ja) * 2010-08-26 2014-11-26 沢井製薬株式会社 ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法
JP6245677B2 (ja) 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
CN104080443B (zh) 2012-03-29 2017-12-12 株式会社大赛璐 含酸式羧甲基纤维素的崩解性颗粒组合物的制法、及该组合物和含该组合物的口腔崩解片剂
CN104010663B (zh) 2012-09-20 2021-02-19 株式会社大赛璐 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂
US9974738B2 (en) * 2013-09-27 2018-05-22 Daicel Corporation Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition
CA2968210A1 (en) * 2014-11-24 2016-06-02 Daicel Corporation A disintegrative particulate composition comprising milled lactose or granulated lactose
TWI690333B (zh) * 2015-06-29 2020-04-11 日商大賽璐股份有限公司 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑

Also Published As

Publication number Publication date
CN104080443B (zh) 2017-12-12
WO2013146917A1 (ja) 2013-10-03
US20200038332A1 (en) 2020-02-06
US12059501B2 (en) 2024-08-13
JP5996633B2 (ja) 2016-09-21
EP2832350B1 (en) 2019-07-17
JPWO2013146917A1 (ja) 2015-12-14
KR101707938B1 (ko) 2017-02-17
EP2832350A4 (en) 2015-11-18
US20150045452A1 (en) 2015-02-12
CN104080443A (zh) 2014-10-01
EP2832350A1 (en) 2015-02-04
TW201400145A (zh) 2014-01-01
KR20140144249A (ko) 2014-12-18
TWI610691B (zh) 2018-01-11
US20150174075A2 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
WO2014014835A8 (en) Crystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid
WO2014101986A8 (en) Dry granulation process for producing tablet compositions of metformin and compositions thereof
WO2013152051A3 (en) Improved production of fatty acid derivatives
IN2013MN02445A (enExample)
HK1206779A1 (en) Modified polynucleotides for the production of nuclear proteins
BR112012011995A2 (pt) uso de prostaglandinas f2alfa e análogos para a cicatrização de lesões da córnea e conjuntiva.
NZ628964A (en) Supercritical hydrolysis of biomass
IN2015DN02907A (enExample)
IN2013CN09704A (enExample)
MX2016004472A (es) Jarabe aglutinante y adhesivo del proceso de fermentación de biomasa lignocelulósica.
WO2012101429A3 (en) A pellet
BR112013022638A2 (pt) processo para a produção de açúcares hemicelulósicos fermentáveis e biomassa com baixo teor de cinzas a partir de biomassa celulósica; processo para a produção de açúcares hemicelulósicos fermentáveis e potência a partir de biomassa celulósica; e processo para a produção de açúcares hemicelulósicos fermentáveis e péletes de biomassa a partir de biomassa celulósica
NZ593787A (en) Lyophilised dabigatran
PH12015500794A1 (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
CA2876532C (en) Process for producing cell culture media
MX359554B (es) Microesferas cristalinas y proceso para fabricacion de las mismas.
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
IN2014DN09313A (enExample)
WO2013092887A3 (en) High surface area composition comprised of lignin
MX2015013801A (es) Proceso de radioetiquetado.
TR201103625A1 (tr) Sefuroksim içeren tablet formülasyonu üretim prosesi.
WO2012159981A3 (en) PROCESS FOR THE PREPARATION OF α-SUBSTITUTED KETONES AND THEIR APPLICATION IN SYNTHESIS OF PHARMACEUTICALLY ACTIVE COMPOUNDS
MX2015011505A (es) Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos.
HK1210436A1 (en) Novel cell compositions and methods
WO2014042605A9 (en) New tiotropium bromide crystalline form